Teledermatology Market (By Type: Products and Services; By Modality: Store-and –Forward and Video Conferencing; By End User: Homecare and Healthcare Units) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global teledermatology market was valued at US$ 10 billion in 2022 and is expected to reach over US$ 62.69 billion by 2032 with a registered CAGR of 20.20% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The Asia Pacific teledermatology market reached US$ 4 billion in 2022 and is projected to grow around US$ 25.08 billion by 2032 growing at a CAGR of 20.4% from 2023 to 2032.
The North America region accounted revenue USD 4.6 billion in 2022. The presence of several top market players such as MDLive and DermatologistsOnCall are fostering the demand for the tele-consultation services. The increased prevalence of various skin diseases in US has augmented the demand for the tele-dermatology. According to the American Academy of Dermatology Association, acne affects around 50 million people annually and it is the most common skin condition. Atopic dermatitis affects around 10% population in US and around 80 million people are affected with hair loss problems. Therefore, the increased prevalence of skin problems coupled with the increased healthcare expenditure and improved access to healthcare facilities has fostered the growth of the tele-dermatology market in North America.
Asia Pacific is estimated to be the most opportunistic market during the forecast period. The rising government initiatives to enhance the healthcare sector and the rising adoption of telehealth and telemedicine are the major factors that drive the growth of the tele-dermatology market in Asia Pacific. Moreover, the rising penetration of internet and the favorable government policies regarding telehealth and reimbursements is expected to drive the growth of the market.
The global teledermatology market gained a rapid momentum in 2022 owing to the outbreak of COVID-19 pandemic. The growing demand for the convenient healthcare services and products among the global consumers is boosting the growth of the global teledermatology market. The rising adoption of the telehealth platforms among the global consumers has positively impacted the growth of the tele-dermatology market. Moreover, the growing prevalence of skin diseases and skin related problems is significantly fueling the demand for the tele-dermatology across the globe. As per the Global Burden of Skin Disease project, the skin disease is the fourth largest cause of non-fatal disease around the globe. Further, it is estimated that around 30% to 70% of the global population is suffering from various skin diseases. Thus, the growing burden of various skin diseases coupled with the rising adoption of the digital health platforms are the major factors behind the growth of the global market.
The rising number of smartphone users and growing penetration of internet across the globe is another important factor that boosts the adoption of the tele-dermatology platforms. According to the International Telecommunication Union, around 4 billion people have access to the internet and majority of them uses smartphones for using the internet. Furthermore, the rising penetration of the social media has boosted the investments by the top market players in the digital marketing and social media marketing to build large customer base. The increasing adoption of the telehealth among the consumers has boosted the availability of the dermatologists and the consultants on the teledermatology platforms. The proliferation of the digital technologies and the integration of the latest technologies like AI and data analytics are fueling the demand for the teledermatology platforms across the globe. Moreover, the development of favorable regulatory framework by the government in various countries regarding the use of telehealth platforms is expected to significantly drive the growth of the tele-dermatology market during the forecast period.
| Report Coverage | Details |
| Market Size In 2023 | USD 11.97 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 20.20% |
| Revenue Projection by 2032 | USD 62.69 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Type, Modality, End Use, Region |
| Companies Mentioned | Diagnosis, Honeywell Life Care Solutions, Philips Healthcare, AMD Global Telemedicine Inc., GE Healthcare, Aerotel Medical Systems, Click Diagnostics, Dermlink, Allscripts Healthcare Solutions Inc., McKesson Corporation |
Based on the type, the services segment was the dominating segment in 2022 and is expected to be the fastest-growing segment during the forecast period. The teledermatology platforms reduce the wait time for various services of the dermatologists like consultations, monitoring, and education services. The lack of adequate number of dermatologists across the globe has fostered the adoption of the teledermatology, which significantly reduces wait time for the patients to receive the services. The conveniences associated with the virtual services have fostered the growth of the services segment in 2020. The growing awareness regarding the teledermatology platforms among the global consumers is expected to drive the growth of the segment during the forecast period.
The store-and-forward segment has garnering a market share of around 70% in 2022. This is attributed to the increased importance of the store-and-forward for capturing skin images properly. The images of skin become necessary in order to acquire accurate diagnosis and treatment.
The video conferencing segment is expected to grow at a moderate rate during the forecast period. The rising prevalence of acne, hair loss, and other skin related problems, the video conferencing with the dermatologists is preferred, which fuels the growth of this segment.
The healthcare units segment dominated the market with largest revenue share in 2022. The increased adoption of the teledermatology platforms in the hospitals and clinics has fueled the growth of the segment. The increased government investments in the adoption of digital technologies in the hospitals have augmented the demand for the teledermatology platforms in the hospitals.
The homecare segment is estimated to be the most opportunistic segment during the forecast period. The rising disposable income, increased healthcare expenditure, and growing geriatric population are the major factors that are expected to drive the growth of the homecare segment in the forthcoming years.
Key Market Developments
In April 2020, Sakhiya Skin Clinic introduced skin care treatment through tele-dermatology platforms which is free of cost. This will boost the adoption of tele-dermatology among the consumers in India.
In June 2021, Hims& Hers acquired Apostrophe, a dermatology start-up. This acquisition will improve Hims& Hers to offer personalized dermatology services to the consumers.
In March 2020, the Ministry of Health and Family Welfare and NITI Aayog introduced an official guideline for the use of telemedicine, in India. This will foster the adoption and growth of the tele-dermatology platforms in India.
The various developmental strategies like acquisition and new product launches with latest and innovative features fosters market growth and offers lucrative growth opportunities to the market players.
Segments Covered in the Report
By Type
By Modality
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Teledermatology Market
5.1. COVID-19 Landscape: Teledermatology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Teledermatology Market, By Product
8.1. Teledermatology Market, by Product Type, 2023-2032
8.1.1. Products
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Services (Teleconsultation, Telemonitoring, Tele-education, Others)
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Teledermatology Market, By Modality
9.1. Teledermatology Market, by Modality, 2023-2032
9.1.1. Store-and –Forward
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Video Conferencing
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Teledermatology Market, By End User
10.1. Teledermatology Market, by End User, 2023-2032
10.1.1. Distribution Channel
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Homecare
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Teledermatology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Modality (2020-2032)
11.1.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Modality (2020-2032)
11.2.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Modality (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Modality (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Modality (2020-2032)
11.3.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Modality (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Modality (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Modality (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Modality (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.5.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Modality (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Modality (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)
Chapter 12. Company Profiles
12.1. Diagnosis
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Honeywell Life Care Solutions
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Philips Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AMD Global Telemedicine Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GE Healthcare
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aerotel Medical Systems
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Click Diagnostics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Dermlink
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Allscripts Healthcare Solutions Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. McKesson Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample